Surely some of the retesting has been done by now,and does not require an announcement.I suspect that the results are encouraging hence the decision to concentrate on cognition.
Ann: ACW announces Phase 2 trial designs for AD & MDD, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.001(4.35%) |
Mkt cap ! $70.90M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.4¢ | 2.3¢ | $21.62K | 930.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 2635718 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 739810 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| ACW (ASX) Chart |